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ABSTRACT 
Objective:  To determine the frequency of early post-operatively complications of transnasal transsphenoidal 
surgery for pituitary adenoma. 
Study design:  Descriptive study. 
Place and Duration of Study:  Pak International Medical Science Khyber Pakhtoonkhawa from 1st February 
2008 to 31
st
 July 2011. 
Material and methods:  A total 41 patients with pituitary adenoma fulfilling the inclusion and exclusion criteria 
were included in this study. All patients were undergone transnasal transsphenoidal surgery. These patients were 
followed up for early complications of transsphenoidal surgery for one month. 
Results:  Out of 41 patients, there were 23 (56.09%) males and 18 (43.9%) females. The age of patients ranged 
from 10 to 70 years. In this study the overall mean age was 44.75 years. Majority of patients fourteen (34.14%) 
were in the age range of 41 – 50 years, followed by eleven (26.8%) patients in age group of 31 – 40 years, seven 
(17.07%) patients were in the age range of 51 – 60 years, five (12.1%) in the age range of 61 – 70 years, three 
(7.31%) in the age group of 21 – 30 years and one (2.4%) in the age group of 10 – 20 years. Early post-operative 
complications were diabetes insipidus in four (7.31%) patients, CSF leak two (4.87%) patients, meningitis in one 
(2.43%) patient and epistaxis in one (2.43%) patient. 
Conclusions:  Surgical complications of Transnasal transsphenoidal surgery are minimal. Transnasal trans-
sphenoidal surgery is a safe and effective treatment for pituitary tumour. 
Key words:  Transnasal transsphenoidal surgery, Pituitary adenomas. 
 
INTRODUCTION 
Pituitary adenomas are normally found in adults with a 
peak incidence during the fourth to the sixth decade of 
life. It represent approximately10% of diagnosed brain 
neoplasms. Autopsy series suggest that 20% of people 
may have a pituitary tumor. It means that majority of 
pituitary tumors are asymptomatic.
1-3
 Pituitary adeno-
mas are often classified based upon their size at the 
time of discovery. Tumors larger than 10 mm in any 
dimension are classified as macroadenomas, whereas 
tumors smaller than 10 mm are classified as microade-
nomas.
4,5
 
 Surgery, radiotherapy, and pharmacotherapy 
constitute the present therapeutic options for the mana-
gement of pituitary adenoma. Surgery, which includes 
transfrontal craniotomy and transsphenoidal surgery, 
allows removal of the adenoma or reduction of the 
tumoral mass and is considered the first – line therapy 
for nonfunctioning adenoma .Transsphenoidal surgery, 
which is standard treatment and causes less morbidity 
than transcranial procedures, can be achieved by two 
approaches i.e Translabial and Transnasal.
6-8
 
 
 Surgical complications following transsphenoidal 
resection of a pituitary lesion These complications are, 
diabetes insipidus (7.6 – 19%), anterior pituitary insuf-
ficiency (7.2 – 19%), meningitis, cerebrospinal fluid 
leak (1.5 – 4.2%), hemorrhage into residual tumor bed 
(0.8 – 2.8%), injury to surrounding structures as optic 
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chiasm injury (0.5 – 2.4%), frontal lobe injury (0.6 – 
1.6%), carotid artery injury (0.4 – 1.4%), death (0.2 – 
1.2%) and others.
1,2,9,10
 
 
MATERIAL AND METHODS 
This was a descriptive study conducted at Pak Interna-
tional Medical Science Khyber pakhtoonkhawa from 
1st February 2008 to 31st July 2011. The sample tech-
nique was non probable purposive and total number of 
patients were forty one. An informed consent was 
taken from all patients both male and females within 
the age range of 10 – 70 years having pituitary ade-
noma diagnosed on MRI Brain were included in this 
study. While patients having adenomas encasing inter-
nal carotid arteries, active sphenoid sinusitis and sus-
pected vascular aneurysm in sella were excluded from 
this study. These patients were operated through trans-
nasal transsphenoidal approach and then followed for 
one month for post-operative complications. The pati-
ents demographic details and post-operative complica-
tions were entered into a semi structured proforma. 
Data was analyzed through statistical program SPSS 
version 16. 
 
RESULTS 
Sex Incidence 
Out of 41 patients, there were 23 (56%) males and 18 
(44%) females (Table 1). 
 
Table 1:  Sex Incidence. 
 
Sex No. % 
Male 23   56 
Female 18   44 
Total 41 100 
 
Age Incidence 
The age of patients ranged from 10 to 70 years. In this 
study the overall mean age was 44.75 years. Majority 
of patients fourteen (34.14%) were in the age range of 
41-50 years (Table 2). 
 
Early Post-operative Complications 
 Early post-operative complications were diabetes 
insipidus in four (7.31%) patients, CSF leak two 
(4.87%) patients, meningitis in one (2.43%) patient 
and epistaxis in one (2.43%) patient (Table 3). 
 
Table 2:  Age Incidence. 
 
S. No. Age Group 
Number of 
Patients 
Percentages 
(%) 
1. 10 – 20   1 2.4 
2. 21 – 30   3 7.3 
3. 31 – 40 11 26.8 
4. 41 – 50 14 34.1 
5. 51 – 60   7 17 
6. 61 – 70   5 12.1 
 
Table 3:  Post operative complications. 
 
S. No. 
Post-operative 
Complications 
Number 
of Patients 
Percentages 
(%) 
1. 
Diabetes 
insipidus 
3 7.31 
2. CSF leak 2 4.87 
3. Meningitis 1 2.43 
4. Epistaxis 1 2.43 
 
DISCUSSION 
Pituitary tumors are associated with significant mor-
bidity and mortality due to hormone hypersecretion 
and mass effects following increased proliferation. The 
treatment modality depends greatly on the type of pitu-
itary adenoma and presenting symptoms .These tumors 
can be treated medically, surgically and pituitary radi-
ation therapy. Some patients may need more than one 
treatment.
2,4
 
 Surgical access to the sphenoid, sellar and para-
sellar has been traditionally done by transcranial and 
transsphenoidal route. Transsphenoidal approaches can 
be done by transnasal and sub labial route. Transnasal 
Transsphenoidal procedure has been increasingly used 
in the resection of pituitary adenomas for its minimal 
invasiveness and less morbidity and mortality as 
compared with transcranial route.
5,11
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 Transsphenoidal surgery is an effective and safe 
treatment for most patients with pituitary adenoma and 
could be considered the first – choice therapy in all 
cases except for prolactinomas responsive to dopamine 
agonists. It can be performed in patients over the age 
of 70 without undo significant risks.
7,8
 
 In our study age range was from 10 to 70 years. 
The mean age of presentation was 44.75 years. Majo-
rity of patients 34.1% were presented in age group of 
41 to 50 years. A study was conducted by Losa M 
showed mean age of 42.6 ± 1.2 years.
12
 Kim MS con-
ducted study in which mean age was 40.2 years.
13
 
 In this study majority of male 23 (56%) presented 
with pituitary adenomas compared to the females 18 
(43.9%) with a male predominance. Nielsen EH sho-
wed male predominance.
14
 
 Shahid K also reported male predominance in his 
study.
15
 
 It is observed that in various international studies 
more women are diagnosed with pituitary adenomas. 
Kim MS conducted study in which 23 (54.8%) women 
and 19 (45.2%) men.
13
 Another group of patient who 
has undergone transsphenoidal microsurgery showed 
that the patient was 59.7% female and 40.3% male.
16
 
Most probable reasons for this difference is that our 
females are shy and hesitant to take the medical con-
sultation for their health related problems so lesser 
number of patient presenting to doctor for treatment. 
There might be some genetic differences responsible 
for this gender distribution. 
 Diabetes Insipidus is a relatively common comp-
lication of transsphenoidal surgery but is most often 
transient. In our study three (7.3%) patients suffered 
diabetes insipidus. Nemergut EC observed 31% pati-
ents having diabetes insipidus post operatively.
17
 Kri-
stof RA showed postoperative diabetes insipidus in 
38.5% of the patients.
18
 Sudhakar N reported that post-
operative diabetes insipidus was commonest complica-
tion that is 23%.
19
 The frequency of diabetes insipidus 
in our study in contrast to the international research is 
low; the most probable reason behind it could be that 
we had not included those cases with extensive para-
sellar and hypothalamic extension. Secondly due to 
differences in sample sizes. 
 In our study post operatively cerebrospinal fluid 
leak observed in two (4.8%) patients. Gondim JA sho-
wed post surgical CSF leak which comprised 3.5%.
20
 
Sudhakar N observed cerebrospinal fluid leak (CSF) in 
13% of patients.
19
 
 Meningitis and epistaxis were other complica-
tions in our study. One patient (2.4%) had meningitis 
after surgery. Meningitis is more common in patients 
who have post operative CSF leak. The total incidence 
of meningitis after transsphenoidal surgery is 1 – 2%.21 
The overall complication rate in our study was 17%. 
Baker F observed overall complications in 26.8% pati-
ents.
22
 The combined risk factors for these complica-
tions are the size of the tumor, hypothalamic exten-
sion, age of the patient and difference in sample size. 
 
CONCLUSIONS 
Surgical complications of Transnasal transsphenoidal 
surgery are minimal. Transnasal trans-sphenoidal sur-
gery is a safe and effective treatment for pituitary 
tumour. 
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